Espansione Group’s eye light_V2 02
June 3, 2024

Espansione Group’s eye-light® Expands Its Horizons: New CE (MDR) Mark for Corneal and Retinal Care

Espansione Group (Zona Artigianale Funo BO, Italy), a leader in medtech innovation in ophthalmology, announced today a major milestone for…

latest posts
Nanoscope Therapeutics 02
October 10, 2024

Nanoscope Therapeutics to Submit BLA for Retinitis Pigmentosa Gene Therapy Candidate MCO-010

Untitled 1
August 20, 2024

Atsena Therapeutics Receives FDA RPD Designation for X-Linked Retinoschisis Gene Therapy Candidate

REGENERON 02
June 17, 2024

Regeneron Awarded Injunctions Blocking Eylea Biosimilars

Espansione Group’s eye light_V2 02
June 3, 2024

Espansione Group’s eye-light® Expands Its Horizons: New CE (MDR) Mark for Corneal and Retinal Care

FDA Approves First Two Aflibercept 2mg Biosimilars With Interchangeability
May 21, 2024

FDA Approves First Two Aflibercept 2mg Biosimilars With Interchangeability

Screen Shot 2023 10 03 at 9.13.51 PM
December 7, 2023

Back with a Roar!: The European VitreoRetinal Society is back after a three-year hiatus

DSC_0001 2
December 1, 2023

From COVID Challenges to Collective Progress: AOS-PAO 2023 Sets Sights on Global Trends and Regional Perspectives

COVER STORY ART
December 7, 2023

THE NOT-SO-SWEET LIFE: Trial and tribulations when navigating the bittersweet realities of diabetic retinopathy

Discover our fascinating content at issuu

explore